Gurbakhash Kaur, MD, discusses how quadruplet regimens, CAR T-cell therapy, and bispecific antibodies are reshaping the role of autologous transplant in multiple myeloma.
Gurbakhash Kaur, MD
Advertisement
Gurbakhash Kaur, MD, is an assistant professor of internal medicine at Mount Sinai Health System.
Articles by Gurbakhash Kaur, MD
Advertisement
Latest Updated Articles
Kaur Discusses the Declining Role of Autologous Transplant in MyelomaSeptember 24th 2026
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Breakthrough Status to Multi-Cancer Early Detection Blood Test
2
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases
3
As New TGCT Therapies Advance, Route, Duration, and Coverage Shape CSF1R Inhibitor Choice
4
Alpha-Emitting RYZ101 Meets Phase 3 PFS End Point in Advanced GEP-NETs
5